Effect of dehydroepiandrosterone on hereditary angioedema

Klin Wochenschr. 1983 Jul 15;61(14):715-7. doi: 10.1007/BF01487618.

Abstract

Hereditary angioneurotic edema (HAE) is a complement-related clinical disorder with a deficiency of the C1 esterase inhibitor protein. Eight patients with severe attacks of the disease were treated with the adrenal "androgen" dehydroepiandrosterone sulphate (DS). Steroid therapy for 3-28 months resulted in dramatic improvement in their clinical state and a moderate increase in the serum concentration of C1 inhibitor. There was a significant increase in the serum level of either unconjugated dehydroepiandrosterone (D) or of DS during treatment.

MeSH terms

  • Adolescent
  • Adult
  • Angioedema / drug therapy*
  • Angioedema / genetics
  • Complement C4 / analysis
  • Complement Inactivator Proteins / blood
  • Dehydroepiandrosterone / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged

Substances

  • Complement C4
  • Complement Inactivator Proteins
  • Dehydroepiandrosterone